Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
Molecular Endocrinology (Baltimore, Md.)|October 15, 2005
Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylationLorraine Lipfert, John E Fisher, Nan Wei, et al.
Nature Communications|May 14, 2026
SIRT6 overexpression counteracts chromatin aging in the male murine liverRon Nagar, Zacharia Schwartz, Almog Katz, et al.
The Journal of Biological Chemistry|October 23, 2009
Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glandsAzriel Schmidt, Shun-Ichi Harada, Donald B Kimmel, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacementsPaul J Coleman, Karen M Brashear, Cecilia A Hunt, et al.
Journal of Medicinal Chemistry|October 17, 2003
Nonpeptide alphavbeta3 antagonists. 8. In vitro and in vivo evaluation of a potent alphavbeta3 antagonist for the prevention and treatment of osteoporosisJohn H Hutchinson, Wasyl Halczenko, Karen M Brashear, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KJacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitorElise Isabel, Kevin P Bateman, Nathalie Chauret, et al.
Physical Review Letters|May 1, 2001
Observation of exotic meson production in the reaction pi- p --> eta'pi- p at 18 GeV/cE I Ivanov, D L Stienike, D I Ryabchikov, et al.
Pageof 35